Extension of time-limited no-action relief for ASX Clear (Futures) Pty Limited with regard to Section 5b(a) of the Commodity Exchange Act and implementing regulations thereunder.
FederalAgency guidance
Ask Donna
How this section applies to your facts.
CFTC Staff Letters (2008-present) › Extension of time-limited no-action relief for ASX Clear (Futures) Pty Limited with regard to Section 5b(a) of the Commodity Exchange Act and implementing regulations thereunder.
Text
Summary: Extension of time-limited no-action relief for ASX Clear (Futures) Pty Limited with regard to Section 5b(a) of the Commodity Exchange Act and implementing regulations thereunder.
U.S. COMMODITY FUTURES TRADING COMMISSION
Three Lafayette Centre
1155 21st Street, NW, Washington, DC 20581
Telephone: (202) 418-5000
Facsimile: (202) 418-5521
www.cftc.gov
Division of Clearing and
Risk
CFTC Letter No. 14-148
No-Action
December 18, 2014
Division of Clearing and Risk
Ms. Amanda J. Harkness
Group General Counsel & Company Secretary
ASX Group
Exchange Centre
20 Bridge Street
Sydney NSW 2000
PO Box H224
Australia Square NSW 1215, Australia
Re:
Extension of No-Action Relief with Regard to Section 5b(a) of the Commodity
Exchange Act and Commission Regulations Thereunder
Dear Ms. Harkness:
This is in response to your letter dated December 2, 2014 (“Letter”) to the Division of
Clearing and Risk (“Division”) of the Commodity Futures Trading Commission
(“Commission”). In the Letter, you request that the Division extend the no-action relief
granted to ASX Clear (Futures) Pty Limited (“ASXCLF”) by letter dated February 6, 2014,1
from the derivatives clearing organization (“DCO”) registration requirement under Section
5b(a) of the Commodity Exchange Act (“CEA”).
Pursuant to the no-action relief, ASXCLF is permitted to clear Australian and New
Zealand dollar-denominated interest rate swaps (“A&NZ$ IRS”) for the proprietary trades of
qualified U.S. clearing participants and their parent entities and affiliates. The relief is set to
expire at the earlier of: (i) December 31, 2014; or (ii) the date on which the Commission
either registers ASXCLF as a DCO under Section 5b(a) of the CEA, or the Commission
exempts ASXCLF from registration pursuant to Section 5b(h) of the CEA
te swaps (“A&NZ$ IRS”) for the proprietary trades of
qualified U.S. clearing participants and their parent entities and affiliates. The relief is set to
expire at the earlier of: (i) December 31, 2014; or (ii) the date on which the Commission
either registers ASXCLF as a DCO under Section 5b(a) of the CEA, or the Commission
exempts ASXCLF from registration pursuant to Section 5b(h) of the CEA.
By letter dated November 26, 2014, the Division informed ASXCLF that it was
amenable to extending the no-action relief until December 31, 2015, subject to ASXCLF
notifying the Division, no later than December 15, 2014, that it will file by June 30, 2015: (i)
a materially complete Form DCO application for registration as a DCO; or (ii) a petition for
1 CFTC Letter 14-07 (February 6, 2014).
Ms. Amanda J. Harkness
December 17, 2014
Page 2
an exemption from registration. The Division’s letter also set forth the standards and
procedures applicable to a petition for an exemption from registration.
In the Letter, you represent that ASXCLF will file, by June 30, 2015, a petition for an
exemption from DCO registration.2 Based on this representation, and in order to allow
ASXCLF the necessary time to prepare and file its petition, the Division will extend the no-
action relief now in effect and will not recommend that the Commission take enforcement
action against ASXCLF for failure to register as a DCO pursuant to the requirements of
Section 5b(a) of the CEA, subject to the following conditions:
(1) Product Scope. This relief is limited to A&NZ$ IRS contracts accepted for
clearing by ASXCLF;
(2) Participant Scope. The relief applies to ASXCLF’s clearing of proprietary trades3
of U.S. Clearing Members;
mmission take enforcement
action against ASXCLF for failure to register as a DCO pursuant to the requirements of
Section 5b(a) of the CEA, subject to the following conditions:
(1) Product Scope. This relief is limited to A&NZ$ IRS contracts accepted for
clearing by ASXCLF;
(2) Participant Scope. The relief applies to ASXCLF’s clearing of proprietary trades3
of U.S. Clearing Members;
(3) Reporting. If a clearing member clears through ASXCLF a swap (referred to as
the “alpha” swap) that has been reported to a Commission-registered swap data
repository (“SDR”) pursuant to Part 45 of the Commission’s regulations,4 then
ASXCLF must report to an SDR, pursuant to Part 45, data regarding the two swaps
resulting from the novation of the alpha swap that had been submitted to ASXCLF for
clearing (referred to as “beta” and “gamma” swaps);5 and
2 Pursuant to an exemption, ASXCLF would be authorized to clear only proprietary swaps positions for U.S.
persons. In order to clear both proprietary and customer swaps positions for U.S. persons, ASXCLF would have
to register with the Commission as a DCO.
3 See 17 C.F.R. § 1.3(y) (definition of “proprietary account”).
4 See Swap Data Recordkeeping and Reporting Requirements, 77 Fed. Reg. 2136 (Jan. 13, 2012) (adopting Part
45).
5 Pursuant to Regulation 39.12(b)(6), 17 C.F.R. § 39.12(b)(6), during the clearing process, a swap submitted for
clearing to a registered DCO (the alpha swap) is extinguished or terminated, and two new swaps (the beta and
gamma swaps) are created. The registered DCO must then report the beta and gamma swaps to an SDR under
Part 45 and associate the unique swap identifier of the alpha swap with the beta and gamma swaps in order for
the Commission to confirm that such alpha swap was cleared
p submitted for
clearing to a registered DCO (the alpha swap) is extinguished or terminated, and two new swaps (the beta and
gamma swaps) are created. The registered DCO must then report the beta and gamma swaps to an SDR under
Part 45 and associate the unique swap identifier of the alpha swap with the beta and gamma swaps in order for
the Commission to confirm that such alpha swap was cleared. See Statement of the Commission concerning
CME Rule 1001 (March 6, 2013), page 6, available at:
http://www.cftc.gov/ucm/groups/public/@newsroom/documents/file/statementofthecommission.pdf; see also 17
C.F.R. § 45.4(a) (“[R]eporting counterparties and [DCOs] required to report swap continuation data must do so
in a manner sufficient to ensure that all data in the [SDR] concerning the swap remains current and accurate, and
includes all changes to the primary economic terms of the swap occurring during the existence of the swap.”); 77
Fed. Reg. at 2153 (“[T]he final rule requires registered entities and reporting counterparties to report
continuation data in a manner sufficient to ensure that the information in the SDR concerning the swap is current
and accurate, and includes all changes to any of the primary economic terms of the swap.”).
In order to avoid duplicative reporting for such transactions, ASXCLF should have rules that prohibit the Part 45
reporting of the beta and gamma swaps by the original counterparties to the alpha swap. These rules should make
Ms. Amanda J. Harkness
December 17, 2014
Page 3
the swap is current
and accurate, and includes all changes to any of the primary economic terms of the swap.”).
In order to avoid duplicative reporting for such transactions, ASXCLF should have rules that prohibit the Part 45
reporting of the beta and gamma swaps by the original counterparties to the alpha swap. These rules should make
Ms. Amanda J. Harkness
December 17, 2014
Page 3
(4) Limited Duration. The no-action relief shall expire at the earlier of: (i) December
31, 2015 or (ii) the date upon which the Commission exempts ASXCLF from
registration as a DCO under Section 5b(h) of the CEA.
The position taken herein concerns enforcement action only and does not represent a
legal conclusion with respect to the applicability of any provision of the CEA or the
Commission’s regulations. In addition, the Division’s position does not necessarily reflect the
views of the Commission or any other division or office of the Commission. Because this
position is based upon the representations contained in the Letter, it should be noted that any
different, changed, or omitted material facts or circumstances may require a different
conclusion or render this letter void. Finally, as with all no-action letters, the Division retains
the authority to condition further, modify, suspend, terminate, or otherwise restrict the terms
of the no-action relief provided herein, in its discretion.
Should you have any questions, please do not hesitate to contact Eileen Donovan,
Acting Deputy Director, at (202) 418-5096, edonovan@cftc.gov; or Andrea Musalem, Special
Counsel, at (202) 418-5167, amusalem@cftc.gov.
Sincerely,
Phyllis Dietz
Acting Director
it clear to market participants that ASXCLF is reporting the beta and gamma swaps as if it were a registered
DCO under the Part 45 rules.
This is a copy of a public record, reproduced as it was published. It is not legal advice, and it may not be the version a court would rely on. Check the official source before you cite it.